Literature DB >> 33529937

Antibiotics, rational drug use and the architecture of global health in Zimbabwe.

Justin Dixon1, Salome Manyau2, Faith Kandiye3, Katharina Kranzer4, Clare I R Chandler5.   

Abstract

Rising concerns around antimicrobial resistance (AMR) have led to a renewed push to rationalise antibiotic prescribing in low- and middle-income countries (LMICs). There is increasing unease in conceptualising antibiotic use as individuals behaving '(ir)rationally' and recognition that rising use is emergent of and contributing to wider economic and political challenges. But in between these individual and societal 'drivers' of antibiotic use is an everyday articulation of care through these substances, written-in to the scripts, delivery chains and pedagogics of global healthcare. This article focuses on this everyday 'architecture' that over time and across spaces has knitted-in antibiotics and rhetorics of control that inform current responses to AMR. Based on historically informed ethnographic research in Zimbabwe, we examine points of continuity and change between 20th Century rational drug use (RDU) discourses and contemporary socio-political formations around AMR and antimicrobial stewardship (AMS), paying particular attention to their co-evolution with the process of pharmaceuticalisation. We illustrate how the framework and techniques of RDU were embedded within programmes to increase access to essential medicines and as such complemented the building of one of Africa's strongest postcolonial health systems in Zimbabwe. Whilst 20th Century RDU was focused on securing the health and safety of patients and affordability for systems, AMS programmes aim to secure medicines. Continuous through both RDU and AMS programmes is the persistent rhetoric of 'irrational use'. Health workers in Harare, attuned to the values and language of these programmes, enact in their everyday practice an architecture in which antibiotics have been designed-in. This research illustrates the struggle to optimise antibiotic use within current framings for action. We propose a reconfiguring of the architecture of global health such that frontline prescribers are able to provide 'good' care without necessarily turning to antibiotics. To design-out antibiotic reliance would require attention beyond '(ir)rationality', to the redrafting of blueprints that inscribe practice.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibiotic use; Antimicrobial resistance; Ethnography; Global health; Rational drug use; Stewardship; Zimbabwe

Mesh:

Substances:

Year:  2020        PMID: 33529937     DOI: 10.1016/j.socscimed.2020.113594

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

1.  Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance.

Authors:  Abul Kalam; Shahanaj Shano; Mohammad Asif Khan; Ariful Islam; Narelle Warren; Mohammad Mahmudul Hassan; Mark Davis
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

2.  Antibiotic stories: a mixed-methods, multi-country analysis of household antibiotic use in Malawi, Uganda and Zimbabwe.

Authors:  Justin Dixon; Eleanor Elizabeth MacPherson; Susan Nayiga; Salome Manyau; Christine Nabirye; Miriam Kayendeke; Esnart Sanudi; Alex Nkaombe; Portia Mareke; Kenny Sitole; Coll de Lima Hutchison; John Bradley; Shunmay Yeung; Rashida Abbas Ferrand; Sham Lal; Chrissy Roberts; Edward Green; Laurie Denyer Willis; Sarah G Staedke; Clare I R Chandler
Journal:  BMJ Glob Health       Date:  2021-11

3.  Wars and sweets: microbes, medicines and other moderns in and beyond the(ir) antibiotic era.

Authors:  Coll Hutchison
Journal:  Med Humanit       Date:  2022-08-10

4.  Drug utilization evaluation of pantoprazole in Kempegowda Institute of Medical Sciences (KIMS) hospital and research centre, India.

Authors:  Shamimeh Fallah Ghorbani; Kiran Nagaraju
Journal:  J Family Med Prim Care       Date:  2022-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.